| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 09/10/2002 | US6448201 Benzoylcyclohexanediones and benzoylpyrazoles, their preparation, and their use as herbicides and plant growth regulators |
| 09/06/2002 | WO2002068560A1 Luminescent polymers |
| 09/06/2002 | WO2002068394A1 Quinoline derivative as tyrosine kinase inhibitor |
| 09/06/2002 | WO2002067937A1 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment |
| 09/06/2002 | WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 09/06/2002 | WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 09/05/2002 | US20020123509 Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and the preparation thereof |
| 09/05/2002 | US20020123506 7-Heterocyclyl quinoline and thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 09/05/2002 | US20020123498 For inhibiting transport protein; therapy |
| 09/05/2002 | US20020123494 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
| 09/05/2002 | US20020121638 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 09/05/2002 | DE10109856A1 Use of N-phenyl arylamide for treating or preventing chronic or acute hepatitis B viral infections in humans or animals, including co-infections with hepatitis D virus |
| 09/05/2002 | DE10108750A1 Verbessertes Verfahren zur Herstellung von Fluorchinoloncarbonsäuren An improved process for the preparation of Fluorchinoloncarbonsäuren |
| 09/04/2002 | EP1236718A1 Improved process for the preparation of fluoro-quinolonecarboxylic acids |
| 09/04/2002 | EP1236712A1 Amidinophenylpyruvic acid derivative |
| 09/04/2002 | EP1235816A1 Benzoylcyclohexandione and benzoylpyrazols, method for the production and use thereof as herbicides and plant growth regulators |
| 09/04/2002 | EP1080086B1 Dihydropyrimidines |
| 09/04/2002 | EP0929525B1 Heteroaryloxyethylamines as 5-ht1a receptor ligands |
| 09/04/2002 | CN1367169A Substituted 6,6-Hetero-dicycloderivative |
| 09/03/2002 | US6444812 Intermediate compounds in the preparation of farnnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N-or C linked imidazoles |
| 09/03/2002 | US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/2002 | US6444684 Lavendamycin analogs, quinoline-5,8-diones and methods of using them |
| 09/03/2002 | US6444678 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 09/03/2002 | US6444617 Preemergent and postemergent herbicides |
| 08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066437A1 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone |
| 08/29/2002 | WO2002066436A1 Process for preparing 2-(4-chlorobenzolamino) -3-[2(1h) -quinolinon-4-yl]proprionic acid |
| 08/29/2002 | WO2002055516A3 1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a) |
| 08/29/2002 | WO2002030930A3 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 08/29/2002 | WO2002002520A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2002002506A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2002000622A3 Aminoalcohol derivatives |
| 08/29/2002 | WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120145 Inhibiting farnesyl protein transferase. |
| 08/29/2002 | US20020120138 Process for the preparation of fluoroquinolonecarboxylic acids |
| 08/29/2002 | US20020119979 Cancer therapy |
| 08/29/2002 | US20020119960 Drug resistance therapy |
| 08/29/2002 | US20020119150 Administering an effective amount of a CD40:CD154 binding interrupter to primate graft recipient for therapy of rejection of tissue graft |
| 08/29/2002 | CA2438709A1 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone |
| 08/29/2002 | CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/28/2002 | EP1233958A1 Inhibitors of histone deacetylase |
| 08/28/2002 | EP1233947A1 Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| 08/28/2002 | EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease |
| 08/28/2002 | CN1089758C Substituted quinoline herbicide intermediates and preparing process thereof |
| 08/28/2002 | CN1089757C Process for producing aminonitropyridines |
| 08/27/2002 | US6441184 Such as n-benzooxazol-2-yl-3-cyclopentyl-2-(4-methanesulfonyl -phenyl)-propionamide for increasing insulin secretion in the treatment of type ii diabetes |
| 08/27/2002 | US6441176 Method for preparing sodium-hydrogen exchanger type 1 inhibitor |
| 08/27/2002 | US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection |
| 08/27/2002 | US6440995 Quinolin-4-yl derivatives |
| 08/27/2002 | US6440618 Imaging element containing a blocked photographically useful compound |
| 08/27/2002 | US6440440 Biocidal benzylbiphenyl derivatives |
| 08/23/2002 | CA2372381A1 Improved process for the preparation of fluoroquinolonecarboxylic acids |
| 08/22/2002 | WO2002064644A1 Complexed compounds and use thereof for the polymerisation of olefins |
| 08/22/2002 | WO2002064576A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 08/22/2002 | WO2002064569A1 Process for producing quinoline carboxyaldehyde derivative and intermediate thereof |
| 08/22/2002 | WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals |
| 08/22/2002 | WO2002048112A3 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 08/22/2002 | WO2002032869A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 08/22/2002 | US20020115861 Process for preparing 1-substituted, 2-substituted 1H-imidazo [4, 5-c] quinoline-4-amines |
| 08/22/2002 | US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects |
| 08/22/2002 | US20020115671 Inhibitors of p38-a kinase |
| 08/22/2002 | US20020115659 Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance |
| 08/22/2002 | US20020115575 Lubricating oil composition |
| 08/22/2002 | DE10108271A1 Chinolin-, Isochinolin- und Phthalazinderivate als Antagonisten des Gonadotropin freisetzenden Hormons Quinoline, isoquinoline and phthalazine derivatives releasing as antagonists of gonadotropin hormone |
| 08/22/2002 | CA2426535A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 08/21/2002 | EP1232150A1 Urea derivatives as anti-inflammatory agents |
| 08/21/2002 | EP1231919A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 08/21/2002 | EP0675715B1 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
| 08/21/2002 | CN1365355A Quinoline derivatives as inhibitors of MEK enzymes |
| 08/21/2002 | CN1365354A Novel naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 08/21/2002 | CN1365347A Anthracene derivatives and organic electroleuminescents device made by using the same |
| 08/21/2002 | CN1364847A Metal ligand compound, luminous device and display device |
| 08/20/2002 | US6437135 Oxidizing 2-cyclopropyl-4-(4-fluorophenyl)-3-hydroxymethylquinoline with a hypohalogenous acid salt and a quaternary ammonium salt to produce 2-cyclopropyl-4-(4-fluorophenyl)-quinoline-3-carbaldehyde |
| 08/20/2002 | US6436999 Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them |
| 08/20/2002 | US6436978 For preventing or treating disorders modulated by alpha-2 adrenoceptors |
| 08/15/2002 | WO2002062763A2 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas |
| 08/15/2002 | WO2002062762A2 Potassium channel openers |
| 08/15/2002 | WO2002062750A1 Cannabinoid receptor ligands |
| 08/15/2002 | WO2002062745A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 08/15/2002 | WO2001072685B1 Polyamine analogues as cytotoxic agents |
| 08/15/2002 | US20020111372 Fused heteroaromatic glucokinase activators |
| 08/15/2002 | US20020111364 ABCA-1 elevating compounds |
| 08/15/2002 | CA2437405A1 Potassium channel openers |
| 08/14/2002 | EP1230235A1 Compounds with antibacterial and antiparasitic properties |
| 08/14/2002 | EP1230219A1 Aromatic sulfons hydroxamic acid metalloprotease inhibitor |
| 08/14/2002 | EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/14/2002 | EP0722439B1 Hiv protease inhibitors |
| 08/14/2002 | DE10107045A1 Verfahren zur Polymerisation von Olefinen A process for the polymerization of olefins |
| 08/14/2002 | DE10105014A1 Neues Verfahren zur Herstellung von Monoamiden der DTPA New process for the preparation of monoamides of the DTPA |
| 08/14/2002 | CN1364158A Mutilin derivatives and their use as antibacterials |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/13/2002 | US6433188 Fused heteroaromatic glucokinase activators |
| 08/13/2002 | US6432989 Use of CRF antagonists to treat circadian rhythm disorders |
| 08/13/2002 | US6432977 Salts of quinoline derivatives as NK3 antagonists |
| 08/13/2002 | US6432962 Antiinflammatory agents |
| 08/13/2002 | US6432949 Amide derivatives useful as inhibitors of the production of cytokines |
| 08/08/2002 | WO2002060876A1 Triaryl compounds and utilization thereof |